Steven Cohen Castle Biosciences Inc Transaction History

Point72 Asset Management, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $586,976 - $897,260	44,200 New	44,200 $746,000
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $1.63 Million - $2.38 Million	83,466 Added 41.45%	284,847 $6.47 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $3.64 Million - $6.04 Million	201,381 New	201,381 $4.74 Million
Q2 2022 Aug 15, 2022	SELL	$16.0 - $45.99 $9.97 Million - $28.7 Million	-623,291 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $4.66 Million - $6.6 Million	140,439 Added 29.09%	623,291 $28 Million

Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $14.8 Million - $25.7 Million	379,673 Added 367.98%	482,852 $20.7 Million
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $6.2 Million - $8.01 Million	103,179 New	103,179 $6.86 Million
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $4.78 Million - $7.9 Million	-81,145 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $3.54 Million - $5.93 Million	81,145 New	81,145 $5.45 Million
Q3 2020 Nov 16, 2020	SELL	$38.47 - $52.03 $1.69 Million - $2.29 Million	-44,022 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $449,083 - $708,030	16,462 Added 59.73%	44,022 $1.66 Million
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $636,084 - $979,206	27,560 New	27,560 $822,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.